A +A Healthcare study undertaken with 95 patients who wore Narval CC (Equinoxe in France) in 2011.
Peepard,T. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med, 342 (2000), pp. 1378-1384.
3: Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-53.
4: Meslier N, Racineux JL. Ronflement et syndrome de haute résistance. Rev Mal Respir 2004 ; 21 : 2S35-2S42.
5: Young T et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328(17):1230–5.
6: Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnea: a long-term follow-up. Eur Respir J. 2006 Sep;28(3):596-602.
7: Peepard T. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000), pp. 1378-1384.
8: Ellen et al. Systematic review of motor vehicle crash risk in persons with sleep apnea. J Clin Sleep Med. 2006 Apr 15;2(2):193-200.
9: Vecchierini MF & al. A custom-made mandibular repositioning device for obstructive sleep apnea-hypopnoea syndrome: the ORCADES study. Sleep Med. 2016 Mar;19:131-40. doi: 10.1016.